Zuo Y, Li T, Yang S, Chen X, Tao X, Dong D
Front Pharmacol. 2025; 15:1466877.
PMID: 40034145
PMC: 11873565.
DOI: 10.3389/fphar.2024.1466877.
You C, Guo J, Xun Y
BMC Nephrol. 2025; 26(1):93.
PMID: 39994543
PMC: 11849263.
DOI: 10.1186/s12882-025-03974-y.
Langthaler K, Jones C, Saaby L, Bundgaard C, Brodin B
Fluids Barriers CNS. 2024; 21(1):11.
PMID: 38273301
PMC: 10809502.
DOI: 10.1186/s12987-023-00495-4.
Hau R, Tash J, Georg G, Wright S, Cherrington N
J Pharmacol Exp Ther. 2022; 382(3):299-312.
PMID: 35779861
PMC: 9426764.
DOI: 10.1124/jpet.122.001195.
Andre C, Mernissi T, Choukroun G, Bennis Y, Kamel S, Liabeuf S
Toxins (Basel). 2022; 14(1).
PMID: 35050992
PMC: 8780284.
DOI: 10.3390/toxins14010015.
Diclofenac toxicity in susceptible bird species results from a combination of reduced glomerular filtration and plasma flow with subsequent renal tubular necrosis.
Nethathe B, Chipangura J, Hassan I, Duncan N, Adawaren E, Havenga L
PeerJ. 2021; 9:e12002.
PMID: 34513332
PMC: 8388555.
DOI: 10.7717/peerj.12002.
Membrane Carriers and Transporters in Kidney Physiology and Disease.
Drozdzik M, Drozdzik M, Oswald S
Biomedicines. 2021; 9(4).
PMID: 33919957
PMC: 8070919.
DOI: 10.3390/biomedicines9040426.
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database.
Russom M, Fitsum Y, Abraham A, Savage R
Drugs Real World Outcomes. 2021; 8(3):263-275.
PMID: 33786776
PMC: 8324666.
DOI: 10.1007/s40801-021-00240-z.
Expression and phylogeny of multidrug resistance protein 2 and 4 in African white backed vulture .
Nethathe B, Abera A, Naidoo V
PeerJ. 2020; 8:e10422.
PMID: 33344079
PMC: 7718797.
DOI: 10.7717/peerj.10422.
Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters.
Park E, Park R, Jeon J, Cho Y, Lee J, Kang H
Pharmaceutics. 2020; 12(11).
PMID: 33138123
PMC: 7692329.
DOI: 10.3390/pharmaceutics12111036.
Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions.
Antonescu I, Karlgren M, Pedersen M, Simoff I, Bergstrom C, Neuhoff S
Pharmaceutics. 2020; 12(4).
PMID: 32344570
PMC: 7238232.
DOI: 10.3390/pharmaceutics12040390.
Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence.
Broughton-Neiswanger L, Rivera-Velez S, Suarez M, Slovak J, Pineyro P, Hwang J
PLoS One. 2020; 15(2):e0228989.
PMID: 32053695
PMC: 7018043.
DOI: 10.1371/journal.pone.0228989.
Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters.
Huo X, Meng Q, Wang C, Wu J, Wang C, Zhu Y
Br J Pharmacol. 2020; 177(9):1933-1948.
PMID: 32000294
PMC: 7161545.
DOI: 10.1111/bph.14957.
Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.
Nigam S, Bush K
Nat Rev Nephrol. 2019; 15(5):301-316.
PMID: 30728454
PMC: 6619437.
DOI: 10.1038/s41581-019-0111-1.
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.
Lozano E, Briz O, Macias R, Serrano M, Marin J, Herraez E
J Pers Med. 2018; 8(2).
PMID: 29659532
PMC: 6023491.
DOI: 10.3390/jpm8020014.
Renal Drug Transporters and Drug Interactions.
Ivanyuk A, Livio F, Biollaz J, Buclin T
Clin Pharmacokinet. 2017; 56(8):825-892.
PMID: 28210973
DOI: 10.1007/s40262-017-0506-8.
A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.
Nieskens T, Peters J, Schreurs M, Smits N, Woestenenk R, Jansen K
AAPS J. 2016; 18(2):465-75.
PMID: 26821801
PMC: 4779111.
DOI: 10.1208/s12248-016-9871-8.
Organic anion transporter 2 transcript variant 1 shows broad ligand selectivity when expressed in multiple cell lines.
Hotchkiss A, Berrigan L, Pelis R
Front Pharmacol. 2015; 6:216.
PMID: 26500550
PMC: 4594013.
DOI: 10.3389/fphar.2015.00216.
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.
Mazaleuskaya L, Sangkuhl K, Thorn C, FitzGerald G, Altman R, Klein T
Pharmacogenet Genomics. 2015; 25(8):416-26.
PMID: 26049587
PMC: 4498995.
DOI: 10.1097/FPC.0000000000000150.
Synthesis and antiplatelet activity of antithrombotic thiourea compounds: biological and structure-activity relationship studies.
Lourenco A, Saito M, Dorneles L, Viana G, Sathler P, Aguiar L
Molecules. 2015; 20(4):7174-200.
PMID: 25903367
PMC: 6272548.
DOI: 10.3390/molecules20047174.